| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $620.7M | +26.6% |
| R&D Expense | $71.6M | +44.7% |
| SG&A Expense | $132.5M | +20.0% |
| Operating Income | -$30.6M | -12.5% |
| Pre-tax Income | -$64.5M | +29.9% |
| Income Tax | -$4.7M | +53.4% |
| Net Income | -$59.8M | +27.0% |
| EPS (Basic) | -$0.31 | +62.2% |
| EPS (Diluted) | -$0.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.6M | -1.5% |
| Accounts Receivable | $48.0M | +18.6% |
| Current Assets | $180.6M | +5.2% |
| Total Assets | $1.59B | -4.3% |
| Current Liabilities | $105.1M | +1.6% |
| Long-term Debt | $536.4M | -1.8% |
| Total Liabilities | $685.0M | +1.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.8M | +72.9% |
| Capital Expenditures | $2.6M | -17.3% |
| Investing Cash Flow | -$18.1M | +95.2% |
| Financing Cash Flow | -$47.3M | -113.9% |
| Free Cash Flow | $62.2M | +81.0% |
| +62.2% |
| Stockholders' Equity |
| $906.7M |
| -8.0% |